Can you provide simple explanations of the pathophysiology and management for all types of headaches?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Headache Scenarios: Pathophysiology and Management

1. MIGRAINE HEADACHE

Pathophysiology

Migraine is a neurobiological brain disorder, not simply a vascular headache 1. The pain arises from cortical spreading depolarization (abnormal electrical waves across the brain), trigeminovascular system activation (nerves around blood vessels in the brain), and neurogenic inflammation involving calcitonin gene-related peptide (CGRP) release 1. Think of it as the brain's pain network becoming hyperexcitable and triggering inflammation around brain blood vessels.

Clinical Features

  • Unilateral throbbing pain (though can be bilateral)
  • Lasts 4-72 hours
  • Associated with nausea, vomiting, photophobia (light sensitivity), phonophobia (sound sensitivity)
  • Worsened by physical activity
  • May have aura (visual disturbances, numbness) before headache in 20-30% of patients

Management Algorithm

ACUTE TREATMENT - Stepped Approach:

First-Line (Mild-Moderate):

  • NSAIDs: Ibuprofen 400-800mg, aspirin 650-1000mg, or diclofenac potassium 2
  • Combination: Aspirin + acetaminophen + caffeine 3
  • Treat EARLY when pain is mild - this is critical for efficacy 3, 2

Second-Line (Moderate-Severe or Failed NSAIDs):

  • Triptans (sumatriptan, rizatriptan, zolmitriptan) - take when headache is still mild 2
  • If one triptan fails, try another - they work differently in different people 2
  • For vomiting: Sumatriptan subcutaneous injection 2
  • Combine triptan with fast-acting NSAID (naproxen sodium, ibuprofen, diclofenac) to prevent relapse 2

Third-Line (All triptans failed):

  • Gepants (ubrogepant, rimegepant) or ditans (lasmiditan) 2

Adjunct Therapy:

  • Metoclopramide or prochlorperazine for nausea 3
  • Use non-oral routes if vomiting present 3

AVOID: Acetaminophen alone (ineffective), opioids (cause dependency and rebound headaches), barbiturates 3, 2

PREVENTIVE TREATMENT (if ≥2 disabling days/month):

  • Beta-blockers (propranolol)
  • Topiramate or valproate
  • Tricyclic antidepressants (amitriptyline)
  • Lisinopril, angiotensin-receptor blockers
  • Magnesium, memantine
  • CGRP monoclonal antibodies (galcanezumab, fremanezumab, erenumab) 4
  • Atogepant (oral gepant) 4

For Chronic Migraine (≥15 days/month):

  • OnabotulinumtoxinA injections 4
  • NOT for episodic migraine 4

2. TENSION-TYPE HEADACHE (TTH)

Pathophysiology

Constant overcontraction of scalp and neck muscles with central sensitization 5. Unlike migraine, this is NOT primarily vascular. The brain's pain processing becomes sensitized, amplifying signals from tight muscles. Think of it as a tight band squeezing around the head.

Clinical Features

  • Bilateral, pressing/tightening quality (NOT throbbing)
  • Mild to moderate intensity
  • NOT worsened by physical activity
  • No nausea/vomiting (key difference from migraine)
  • May have mild photophobia OR phonophobia (not both)
  • Frontal, temporal, or occipital location
  • Can be episodic (<15 days/month) or chronic (≥15 days/month)

Management Algorithm

ACUTE TREATMENT:

  • Ibuprofen 400mg 4
  • Acetaminophen 1000mg 4
  • NSAIDs (aspirin, naproxen) 5
  • Heat, massage, stretching of neck/scalp muscles 5

PREVENTIVE TREATMENT (Chronic TTH):

  • Amitriptyline (tricyclic antidepressant) - first-line 4, 5
  • Muscle relaxants 5
  • Physical therapy or aerobic exercise 4

AVOID: Opioids, frequent analgesic use (causes medication overuse headache)

3. CLUSTER HEADACHE

Pathophysiology

Similar to migraine but involves hypothalamic dysfunction and autonomic nervous system activation 5. The hypothalamus (brain's clock) triggers attacks at specific times, causing severe trigeminal nerve pain and autonomic symptoms (tearing, nasal congestion).

Clinical Features

  • Severe, unilateral orbital/periorbital pain (around/behind one eye)
  • Excruciating intensity - often described as worst pain imaginable
  • Lasts 15-180 minutes
  • Occurs in clusters: multiple attacks per day for weeks/months, then remission
  • 90% have episodic pattern; 10% chronic (no remission >1 year)
  • Ipsilateral autonomic features: tearing, red eye, nasal congestion, ptosis, miosis, facial sweating
  • Restlessness/agitation during attack (unlike migraine where patients lie still)
  • NO aura, rare nausea/vomiting
  • Often occurs at same time daily, frequently wakes patient from sleep

Management Algorithm

ACUTE TREATMENT:

  • 100% oxygen 7-12 liters/min via non-rebreather mask for 15 minutes 6
  • Sumatriptan subcutaneous 6mg (maximum twice daily) 6
  • Intranasal ergotamine 5

PREVENTIVE TREATMENT (during cluster period):

  • Verapamil (calcium channel blocker) - first-line
  • Prednisone (short-term for breaking cycle) 5
  • Lithium 5
  • Methysergide 5

AVOID: Alcohol and vasodilating agents during cluster periods 5

4. MEDICATION OVERUSE HEADACHE (REBOUND HEADACHE)

Pathophysiology

Chronic use of acute headache medications causes central sensitization and paradoxical worsening of headaches 3. The brain adapts to constant medication, requiring more for effect and experiencing withdrawal between doses.

Clinical Features

  • Headache ≥15 days/month
  • Regular overuse of acute medication for >3 months:
    • Triptans, ergots, opioids, combination analgesics: ≥10 days/month
    • Simple analgesics (NSAIDs, acetaminophen): ≥15 days/month
  • Headache worsens or fails to improve despite medication
  • Often starts as episodic migraine or TTH

Management Algorithm

  1. Identify and stop the overused medication (may require gradual taper for opioids/barbiturates)
  2. Expect withdrawal period (2-10 days of worsening headache)
  3. Bridge therapy: Short course of prednisone or naproxen
  4. Start preventive medication immediately
  5. Strict limits on acute medication: Maximum 2 days/week for triptans, 3 days/week for NSAIDs
  6. Patient education on medication limits

CRITICAL PITFALL: Opioids and barbiturates have highest risk - avoid these for chronic headaches 3

5. CHRONIC PAROXYSMAL HEMICRANIA

Pathophysiology

Rare variant of cluster headache with similar trigeminovascular activation but absolute response to indomethacin (diagnostic feature) 6.

Clinical Features

  • Similar to cluster: severe unilateral orbital pain with autonomic features
  • Shorter duration: 2-30 minutes
  • More frequent: 5-40 attacks per day
  • More common in women (unlike cluster)

Management

  • Indomethacin 25-50mg three times daily - diagnostic and therapeutic 6
  • If indomethacin ineffective, diagnosis is wrong

6. TRIGEMINAL NEURALGIA

Pathophysiology

Demyelination or compression of trigeminal nerve (often by blood vessel), causing hyperexcitability and spontaneous firing 6.

Clinical Features

  • Brief, electric shock-like pain (seconds to 2 minutes)
  • Unilateral facial pain in trigeminal nerve distribution (V2, V3 most common)
  • Triggered by light touch: talking, chewing, brushing teeth, wind on face
  • Pain-free between attacks
  • Most intense facial pain described

Management Algorithm

  1. Carbamazepine 200-400mg twice daily - first-line 6
  2. Alternative: Oxcarbazepine, gabapentin, baclofen
  3. Surgical options if medication fails:
    • Microvascular decompression
    • Gamma knife radiosurgery
    • Radiofrequency ablation

RED FLAGS - SECONDARY HEADACHE (Requires Urgent Evaluation)

These indicate potentially dangerous causes requiring neuroimaging:

  • Thunderclap headache (sudden, severe, maximal at onset) → subarachnoid hemorrhage 2
  • New headache after age 50 → temporal arteritis, tumor 2, 3
  • Progressive worsening headache → tumor, increased intracranial pressure 2, 3
  • Headache with fever and neck stiffness → meningitis 2
  • Focal neurological signs (weakness, vision loss, confusion) → stroke, tumor 2, 3
  • Headache after head trauma → subdural hematoma 2, 3
  • Headache worsened by Valsalva (coughing, sneezing, bending) → increased intracranial pressure 2, 3
  • Headache awakening patient from sleep → tumor 3
  • Atypical aura (>60 minutes, motor weakness) → stroke, TIA 2

Neuroimaging indications 3:

  • Any red flag present
  • Rapidly increasing headache frequency
  • Focal neurologic signs
  • Atypical features not fitting primary headache pattern

KEY PRINCIPLES ACROSS ALL HEADACHES

  1. Early treatment is more effective - take medication when pain is mild 3, 2
  2. Limit acute medication use - maximum 2-3 days/week to prevent medication overuse headache 2
  3. Consider preventive therapy if headaches impair quality of life ≥2 days/month 2
  4. Avoid opioids and barbiturates - high risk of dependency and rebound 3, 2
  5. Non-pharmacologic approaches: aerobic exercise, physical therapy, sleep hygiene, stress management 4
  6. Rule out secondary causes with red flag screening 2, 3

References

2
Guideline

diagnosis and management of migraine in ten steps.

Nature Reviews Neurology, 2021

3
Guideline

management of the acute migraine headache.

American family physician, 2002

6
Research

[Neurologic diagnosis and therapy of headaches].

Revue de stomatologie et de chirurgie maxillo-faciale, 2000

Related Questions

What is the textbook definition of a migraine?
What are the 2025 American Headache Society guidelines for emergency department management of migraine?
How should I treat a 66-year-old patient with migraines?
In a 19-year-old woman with a 6-year history of migraines now occurring 1–2 times per week and interfering with her studies, what is the most appropriate next step in management?
What does an acute post‑traumatic intractable headache mean?
Is it safe to combine mosapride with a proton‑pump inhibitor (e.g., omeprazole), and what dosing regimen and precautions should be followed?
For occupational arsenic exposure monitoring, is urine arsenic measurement preferred over serum arsenic measurement?
How can NSTEMI be distinguished from STEMI in a patient with baseline ST‑segment abnormalities (e.g., left bundle‑branch block, left ventricular hypertrophy, or chronic ST depressions)?
When and how can anti‑tuberculosis therapy for tuberculous lymphadenitis be discontinued?
In a 75-year-old woman attempting weight loss who reports taking over‑the‑counter pills of unknown name, with serum sodium 134 mmol/L, serum potassium 3.2 mmol/L, serum chloride 90 mmol/L, serum bicarbonate 22 mmol/L, urine potassium 15 mmol/L, and urine chloride 13 mmol/L, what is the most likely cause of her hypokalemia?
Can a lymph node infiltrated by malignant cells become necrotic?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.